Truist Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $993K | Sell |
3,561
-356
| -9% | -$103K | ﹤0.01% | 1715 |
|
|
2025
Q4 | $1.19M | Sell |
3,917
-7,579
| -66% | -$2.36M | ﹤0.01% | 1568 |
|
|
2025
Q3 | $3.22M | Buy |
11,496
+2,422
| +27% | +$659K | ﹤0.01% | 1107 |
|
|
2025
Q2 | $2.19M | Sell |
9,074
-142
| -2% | -$33.6K | ﹤0.01% | 1229 |
|
|
2025
Q1 | $2.24M | Buy |
9,216
+30
| +0.3% | +$9.03K | ﹤0.01% | 1168 |
|
|
2024
Q4 | $3.02M | Buy |
9,186
+72
| +0.8% | +$24.4K | ﹤0.01% | 1051 |
|
|
2024
Q3 | $3.05M | Buy |
9,114
+183
| +2% | +$58.1K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $2.44M | Sell |
8,931
-1,742
| -16% | -$507K | ﹤0.01% | 1181 |
|
|
2024
Q1 | $3.69M | Sell |
10,673
-962
| -8% | -$316K | 0.01% | 1002 |
|
|
2023
Q4 | $3.76M | Sell |
11,635
-3,184
| -21% | -$998K | 0.01% | 972 |
|
|
2023
Q3 | $5.31M | Buy |
14,819
+31
| +0.2% | +$12K | 0.01% | 824 |
|
|
2023
Q2 | $5.61M | Buy |
14,788
+2,046
| +16% | +$833K | 0.01% | 795 |
|
|
2023
Q1 | $6.1M | Buy |
12,742
+309
| +2% | +$145K | 0.01% | 754 |
|
|
2022
Q4 | $5.23M | Buy |
12,433
+2,543
| +26% | +$1.03M | 0.01% | 807 |
|
|
2022
Q3 | $4.13M | Buy |
9,890
+516
| +6% | +$257K | 0.01% | 859 |
|
|
2022
Q2 | $4.64M | Sell |
9,374
-1,107
| -11% | -$577K | 0.01% | 831 |
|
|
2022
Q1 | $5.9M | Sell |
10,481
-1,315
| -11% | -$793K | 0.01% | 829 |
|
|
2021
Q4 | $8.91M | Sell |
11,796
-570
| -5% | -$427K | 0.01% | 684 |
|
|
2021
Q3 | $9.22M | Buy |
12,366
+298
| +2% | +$223K | 0.02% | 669 |
|
|
2021
Q2 | $7.78M | Sell |
12,068
-98
| -0.8% | -$59.6K | 0.01% | 722 |
|
|
2021
Q1 | $6.95M | Buy |
12,166
+992
| +9% | +$587K | 0.01% | 726 |
|
|
2020
Q4 | $6.51M | Sell |
11,174
-900
| -7% | -$513K | 0.01% | 737 |
|
|
2020
Q3 | $6.22M | Sell |
12,074
-1,200
| -9% | -$608K | 0.01% | 690 |
|
|
2020
Q2 | $5.99M | Buy |
13,274
+755
| +6% | +$333K | 0.01% | 674 |
|
|
2020
Q1 | $4.39M | Buy |
12,519
+106
| +0.9% | +$39K | 0.01% | 709 |
|
|
2019
Q4 | $4.59M | Buy |
12,413
+10,953
| +750% | +$3.86M | 0.01% | 775 |
|
|
2019
Q3 | $486K | Sell |
1,460
-43
| -3% | -$14K | 0.01% | 573 |
|
|
2019
Q2 | $469K | Buy |
1,503
+47
| +3% | +$14.1K | 0.01% | 595 |
|
|
2019
Q1 | $445K | Buy |
1,456
+144
| +11% | +$38.9K | 0.01% | 593 |
|
|
2018
Q4 | $304K | Buy |
1,312
+177
| +16% | +$47.5K | 0.01% | 640 |
|
|
2018
Q3 | $355K | Sell |
1,135
-285
| -20% | -$88.5K | 0.01% | 652 |
|
|
2018
Q2 | $410K | Buy |
+1,420
| New | +$392K | 0.01% | 618 |
|
Other funds holding BIO
VCM
VPM
AI
